Quotes HAVN Life Sciences Inc.

Equities

HAVN

CA4196213058

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange 19:12:37 09/11/2023 GMT 5-day change 1st Jan Change
0.03 CAD -.--% Intraday chart for HAVN Life Sciences Inc. +20.00% -.--%

Performance

6 months-14.29%
1 year-25.00%
3 years-99.86%

Volumes

markets
Daily volume
14 850
Estimated daily volume
14 850
Record volume 1
973 100
Record volume 2
714 600
Record volume 3
601 275
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (CAD)
628 041
Capitalization (USD)
628 041
Net sales ()
0
Free-Float
96.5 %
Free-Float capitalization (CAD)
606 029
Free-Float capitalization (USD)
606 029

Highs and lows

1 year
0.00
Extreme 0
0.05
3 years
0.00
Extreme 0
24.00
5 years
0.00
Extreme 0
45.60
10 years
0.00
Extreme 0
45.60

Indicators

Moving average 5 days
0.03
Moving average 20 days
0.02
Moving average 50 days
0.02
Moving average 100 days
0.03
Price spread / (MMA5)
+11.00%
Price spread / (MMA20)
-37.33%
Price spread / (MMA50)
-27.67%
Price spread / (MMA100)
-11.33%
RSI 9 days
53.67
RSI 14 days
52.62

Sector Comparison - Other Biotechnology & Medical Research

Name Change 5d. change 1st Jan change 1-year change Capi.
-.--%+20.00%-.--%-25.00% 628K
-2.30%+9.42%+22.81%-10.88% 47.9B
-0.23%-0.77%+46.56%-10.68% 41.42B
+1.64%-3.58%-1.88%+20.43% 40.7B
+0.80%+2.89%-6.20%+15.95% 28.92B
+1.98%+3.62%+11.33%+66.05% 25.55B
-0.73%+2.62%-21.00%-28.69% 19.27B
-1.59%+17.90%-1.43%-8.50% 12.15B
+2.08%+0.13%+30.73%+93.79% 12.14B
+0.77%+1.37%-0.48%+23.02% 11.99B
-0.72%+9.34%+18.47%+21.67% 11.64B
-0.93%+0.66%-4.90%-10.17% 9.53B
-2.86%+5.23%+36.16%+60.44% 6.85B
-0.88%+14.12%+15.19%+88.96% 6.71B
+0.68%-0.37%+24.46%-22.95% 6.66B
+4.47%+3.49%+12.33%-29.83% 6.6B
Average+0.30%+6.35%+11.39%+15.22%
Weighted average by Cap.+0.48%+4.05%+13.06%+12.47%

Historical data

DateOpeningHighLowEnd-of-dayVolume
Chart HAVN Life Sciences Inc.
More charts

Monthly variations

Annual change

2024-100.00%
2023-64.71%
2022-98.33%
2021-82.65%
2020+60.66%
  1. Stock Market
  2. Equities
  3. HAVN Stock
  4. Quotes HAVN Life Sciences Inc.